One cohort study assessed the immunogenicity of the Meningococcal C vaccinationin 127 children with JIA, treated with glucocorticoids, conventional DMARDs andbDMARDs (TNF inhibitors and IL-6 inhibitors).29 This evidence concerns the gene TNF and juvenile idiopathic arthritis.